Subject: Health technologies > Diagnostic technologies

This fact sheet describes PATH's work to eliminate malaria, including expanding the use of lifesaving tools, identifying and developing better diagnostics and drugs, devising new strategies for malaria control, and accelerating the development of malaria vaccines.

PATH is a leader in the innovation, promotion, and adoption of diagnostic technologies to support malaria elimination and ultimately eradication. As a whole, malaria-related projects and programs at PATH form a core of organizational expertise and strong infrastructure to accelerate the development and adoption of new and improved malaria diagnostics.

GHTC is a group of 40 nonprofit organizations committed to increasing awareness of the urgent need for health technologies that save lives around the world. Breakthroughs highlights the news and stories that are driving the work we do to advance innovation to save lives.

Innovation for Global Health is the Global Health Technologies Coalition's e-newsletter focusing on the development and delivery of lifesaving health tools to people in need worldwide. The newsletter provides updates on the latest research and policy developments on innovative tools to prevent, diagnose, and treat diseases. It includes news from US agencies, Congress, the current administration, and the global health community at large.

PATH collaborates with the US Department of Defense (DoD) to advance global health innovations. This fact sheet provides examples of successes that PATH, DoD, and our partners have had in working to adapt, test, and expand access to tools and technologies that can reduce illness in the world’s most vulnerable populations.

PATH and the US Department of Health and Human Services (HHS) work together to protect and improve health in developing countries. This fact sheet provides examples of successes that PATH, HHS, and our partners have had in developing and deploying new global health technologies to prevent, detect, and control epidemic and neglected diseases, advance health research, and save lives around the world.

This brochure outlines PATH's work in China, with emphasis on public-private partnerships for product development. Areas of focus include vaccines and immunization, health technologies, and women's health.

This success story displays positive outcomes of PATH's work in the Democratic Republic of Congo related to the control and treatment of multidrug-resistant tuberculosis (MDR-TB), achieved by introducing the innovative GeneXpert diagnostic machine. This work was made possible with funding from the United States Agency for International Development.

This project brief describes PATH’s work in promoting tuberculosis (TB) control in India by building local and national capacities in advocacy, communication, and social mobilization (ACSM) strategies. This work aimed to improve TB case detection and treatment adherence by training local civil-society members and national-level staff to design and implement ACSM work plans. This project was made possible through support from the United States Agency for International Development.

This project brief describes PATH’s work in promoting tuberculosis (TB) control in India by contributing to health human resources development throughout the country. With support from the United States Agency for International Development, PATH worked with Initiatives Inc. to assess the state of human resources working in TB-related capacities in India, to analyze the feasibility of integrating the national TB program with the general health system, and to pilot an integrated model of TB programming within the general health system in four districts. The brief outlines lessons learned that can be applied to future health human resources development in TB-related capacities in India and globally.

As with many other diseases, the burden of breast cancer falls most heavily on poor, marginalized, and rural women due to their unequal access to screening and treatment. This fact sheet describes PATH and our partners’ novel approach to improving early detection, diagnosis, and care in La Libertad, Peru, using a health care model that can be expanded and applied to other low-resource settings.

This project brief outlines PATH’s work in strengthening national laboratories in India to correctly diagnose tuberculosis (TB), including multidrug-resistant tuberculosis (MDR-TB). In collaboration with FIND, the World Health Organization, and other partners, PATH provided intense technical assistance to India's Revised National TB Control Program to introduce new diagnostic technologies into Indian laboratories, improve biosafety and infrastructure, build nationwide laboratory networks, and strengthen quality assurance. This work was made possible through support from the United States Agency for International Development.

This project brief describes one aspect of PATH’s contributions to tuberculosis (TB) control in India. With the support of the United States Agency for International Development, PATH worked with India’s Revised National TB Control Program to implement new national guidelines on airborne infection control in India. Work included developing education materials for health workers and their patients, convening experience-sharing workshops for national TB program staff, and training local engineers and architects to design effective infection-control measures within health facilities.

This project brief describes PATH’s contributions to developing public-private mix (PPM) approaches to TB control in India. With support from the United States Agency for International Development, PATH supported a PPM pilot project in Andhra Pradesh that aimed to train private chemists in identifying presumed TB cases and referring them to government diagnosis centers, promoting community awareness of TB prevention, and reducing the sale of TB drugs to persons without a prescription. This project provided valuable lessons and insights into applying PPM strategies to future TB control projects in India and elsewhere.

This annotated target product profile (TPP) describes the desired characteristics of an HIV self-test and is a result of a review of currently available literature, interviews with key informants/stakeholders, laboratory-generated data on the performance of rapid tests, and early usability studies in Kenya, Malawi, and South Africa. The purpose of the TPP is to provide a common foundation for the development of HIV self-tests that contains sufficient detail to allow device developers and key stakeholders to understand the characteristics a test must have to be successful.

This fact sheet provides an overview of PATH’s work in noncommunicable diseases (NCDs). Our goal is to reduce preventable morbidity and mortality by using innovation and technology to increase access to prevention and care for NCDs in low-resource settings.

Part of the Technology Updates series, this fact sheet describes PATH’s work with diagnostic developers and stakeholders from around the world to develop a rapid, point-of-care diagnostic test for glucose-6 phosphate dehydrogenase (G6PD) deficiency. A reliable test for G6PD at the point of care is essential to malaria elimination strategies.

This issue of Directions in Global Health highlights PATH’s work over a decade to improve control of Japanese encephalitis and make an affordable vaccine from China widely available. It includes an editorial by Dr. Kathy Neuzil, who directs PATH’s Vaccine Access and Delivery Global Program. Other articles cover work to bring a rapid test for river blindness to market, use community-led videos to improve health, tackle diabetes and tuberculosis, and help public health managers with information systems.